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Geography of Human Genes, which detailed our collective
knowledge about the distribution of traditional serogenetic
variation within a holistic anthropological framework, and the
appearance of Human Evolutionary Genetics. This new com-
pendium emphasizes the enormous explosion in knowledge
derived from human haploid systems and molecular genetic
markers, and, as such, it is a most worthy successor. It should
quickly become the book to consult for genetic information
pertinent to the evolution of our species. To the authors, I offer
both a sincere thank you and a hearty congratulations for a
job well done!
STEPHEN L. ZEGURA
Anthropology Department
The University of Arizona
Tucson
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Facioscapulohumeral Muscular Dystrophy: Clinical
Medicine and Molecular Cell Biology. Edited by Meena
Upadhyaya and David N. Cooper. New York: BIOS
Scientific Publishers, 2004. Pp. 250. $149 hardcover.
Facioscapulohumeral muscular dystrophy (FSHD) is a fasci-
nating disorder from both clinical and molecular standpoints.
The molecular basis of FSHD is still being debated and refined,
15 years after it was localized by linkage to chromosome 4q
and 13 years after the causative genetic rearrangement was
identified. This book presents a comprehensive compendium
of the state of knowledge about all aspects of FSHD as of
approximately 2003, with chapters written by clinicians and
investigators who have been intimately involved in contrib-
uting to this knowledge base.
For those interested in clinical aspects of FSHD, there are
three chapters that discuss the typical and unusual clinical
features of the disease and one devoted to the retinal changes
seen in some patients. Genetic counseling for FSHD, which is
often complex, is discussed in detail by two different clinicians
in separate chapters, and a third chapter (on genotype-phe-
notype correlation) covers many of the same issues. These
chapters address interpretation of genetic test results, clinical
anticipation (which is suggested in some families but is not
uniformly agreed on), and the effect of sex on disease severity.
An additional chapter covers genetic mosaicism in FSHD. Cli-
nicians who are interpreting reports of DNA testing for FSHD
will also find the chapter entitled “Molecular Diagnosis of
FSHD” extremely helpful. Finally, there is a brief chapter re-
viewing clinical management.
Most of the remainder of the book is devoted to the un-
folding story of the molecular basis of this disorder, beginning
with linkage analysis and identification of the subtelomeric
deletion that is the basis of the clinical diagnostic test. Sub-
sequent chapters present proposed mechanisms of disease,
identification of candidate genes, and genomic analysis of the
deletion. The evidence for a genetic derepression model of
pathogenesis is detailed, along with gene expression profiling
that suggests an alternative model.
This book is an ideal resource for someone who wishes to
have an in-depth understanding of FSHD. This includes genetic
counselors or clinicians who deal with many FSHD families,
as well as researchers who are considering entering this field.
The book conveys the current state of understanding, as well
as the remaining questions to be answered and conflicts to be
resolved.
KATHERINE D. MATHEWS
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